240 related articles for article (PubMed ID: 37591946)
1. Transcriptional profiling of canine osteosarcoma identifies prognostic gene expression signatures with translational value for humans.
Mannheimer JD; Tawa G; Gerhold D; Braisted J; Sayers CM; McEachron TA; Meltzer P; Mazcko C; Beck JA; LeBlanc AK
Commun Biol; 2023 Aug; 6(1):856. PubMed ID: 37591946
[TBL] [Abstract][Full Text] [Related]
2. A single-cell RNA sequencing atlas of circulating leukocytes from healthy and osteosarcoma affected dogs.
Ammons DT; Harris RA; Hopkins LS; Kurihara J; Weishaar K; Dow S
Front Immunol; 2023; 14():1162700. PubMed ID: 37275879
[TBL] [Abstract][Full Text] [Related]
3. Characterization of canine osteosarcoma by array comparative genomic hybridization and RT-qPCR: signatures of genomic imbalance in canine osteosarcoma parallel the human counterpart.
Angstadt AY; Motsinger-Reif A; Thomas R; Kisseberth WC; Guillermo Couto C; Duval DL; Nielsen DM; Modiano JF; Breen M
Genes Chromosomes Cancer; 2011 Nov; 50(11):859-74. PubMed ID: 21837709
[TBL] [Abstract][Full Text] [Related]
4. HES1, a target of Notch signaling, is elevated in canine osteosarcoma, but reduced in the most aggressive tumors.
Dailey DD; Anfinsen KP; Pfaff LE; Ehrhart EJ; Charles JB; Bønsdorff TB; Thamm DH; Powers BE; Jonasdottir TJ; Duval DL
BMC Vet Res; 2013 Jul; 9():130. PubMed ID: 23816051
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling of canine osteosarcoma reveals genes associated with short and long survival times.
Selvarajah GT; Kirpensteijn J; van Wolferen ME; Rao NA; Fieten H; Mol JA
Mol Cancer; 2009 Sep; 8():72. PubMed ID: 19735553
[TBL] [Abstract][Full Text] [Related]
6. Canine osteosarcoma genome sequencing identifies recurrent mutations in
Gardner HL; Sivaprakasam K; Briones N; Zismann V; Perdigones N; Drenner K; Facista S; Richholt R; Liang W; Aldrich J; Trent JM; Shields PG; Robinson N; Johnson J; Lana S; Houghton P; Fenger J; Lorch G; Janeway KA; London CA; Hendricks WPD
Commun Biol; 2019; 2():266. PubMed ID: 31341965
[TBL] [Abstract][Full Text] [Related]
7. Canine osteosarcoma: a naturally occurring disease to inform pediatric oncology.
Fenger JM; London CA; Kisseberth WC
ILAR J; 2014; 55(1):69-85. PubMed ID: 24936031
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs at the human 14q32 locus have prognostic significance in osteosarcoma.
Sarver AL; Thayanithy V; Scott MC; Cleton-Jansen AM; Hogendoorn PC; Modiano JF; Subramanian S
Orphanet J Rare Dis; 2013 Jan; 8():7. PubMed ID: 23311495
[TBL] [Abstract][Full Text] [Related]
9. Risk-modeling of dog osteosarcoma genome scans shows individuals with Mendelian-level polygenic risk are common.
Zapata I; Moraes LE; Fiala EM; Zaldivar-Lopez S; Couto CG; Rowell JL; Alvarez CE
BMC Genomics; 2019 Mar; 20(1):226. PubMed ID: 30890123
[TBL] [Abstract][Full Text] [Related]
10. Comparative biology of human and canine osteosarcoma.
Mueller F; Fuchs B; Kaser-Hotz B
Anticancer Res; 2007; 27(1A):155-64. PubMed ID: 17352227
[TBL] [Abstract][Full Text] [Related]
11. Comparative Immunogenomics of Canine Natural Killer Cells as Immunotherapy Target.
Gingrich AA; Reiter TE; Judge SJ; York D; Yanagisawa M; Razmara A; Sturgill I; Basmaci UN; Brady RV; Stoffel K; Murphy WJ; Rebhun RB; Brown CT; Canter RJ
Front Immunol; 2021; 12():670309. PubMed ID: 34594320
[TBL] [Abstract][Full Text] [Related]
12. Vimentin, osteocalcin and osteonectin expression in canine primary bone tumors: diagnostic and prognostic implications.
Amaral CB; Leite JDS; Fonseca ABM; Ferreira AMR
Mol Biol Rep; 2018 Oct; 45(5):1289-1296. PubMed ID: 30066297
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and predictive biomarkers of canine osteosarcoma.
Selvarajah GT; Kirpensteijn J
Vet J; 2010 Jul; 185(1):28-35. PubMed ID: 20493743
[TBL] [Abstract][Full Text] [Related]
14. A genome-wide approach to comparative oncology: high-resolution oligonucleotide aCGH of canine and human osteosarcoma pinpoints shared microaberrations.
Angstadt AY; Thayanithy V; Subramanian S; Modiano JF; Breen M
Cancer Genet; 2012 Nov; 205(11):572-87. PubMed ID: 23137772
[TBL] [Abstract][Full Text] [Related]
15. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
[TBL] [Abstract][Full Text] [Related]
16. miR-1 and miR-133b expression in canine osteosarcoma.
Leonardo L; Laura P; Serena BM
Res Vet Sci; 2018 Apr; 117():133-137. PubMed ID: 29272721
[TBL] [Abstract][Full Text] [Related]
17. The genomic landscape of canine osteosarcoma cell lines reveals conserved structural complexity and pathway alterations.
Megquier K; Turner-Maier J; Morrill K; Li X; Johnson J; Karlsson EK; London CA; Gardner HL
PLoS One; 2022; 17(9):e0274383. PubMed ID: 36099278
[TBL] [Abstract][Full Text] [Related]
18. Analysis of gene expression of prostaglandin EP4 receptor in canine osteosarcoma.
Musser ML; Viall AK; Phillips RL; Hostetter JM; Johannes CM
Can J Vet Res; 2021 Jan; 85(1):68-71. PubMed ID: 33390656
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients.
Hu C; Liu C; Tian S; Wang Y; Shen R; Rao H; Li J; Yang X; Chen B; Ye L
BMC Cancer; 2020 Aug; 20(1):814. PubMed ID: 32854645
[TBL] [Abstract][Full Text] [Related]
20. Comparative Immunology and Immunotherapy of Canine Osteosarcoma.
Mason NJ
Adv Exp Med Biol; 2020; 1258():199-221. PubMed ID: 32767244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
